{"id":"W2341658168","doi":"10.1016/j.jaci.2015.12.670","title":"A Phase 1 First-in-Human Study (B4901001) Evaluating a Novel Anti-IgE Vaccine in Adult Subjects with Allergic Rhinitis","year":2016,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institut de Recherche et de Développement en Agroenvironnement; Pfizer (Canada); Ottawa Allergy Research Corporation","funders":"","keywords":"Medicine; Immunoglobulin E; Omalizumab; Immunology; Immunogenicity; Tolerability; Antigen; Allergy; Adjuvant; Adverse effect; Antibody; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001314503,0.0002237754,0.001005871,0.0003071842,0.00008431189,0.00001561829,0.000130542,0.0002404538,0.0001615014],"category_scores_gemma":[0.0009427287,0.0001357905,0.0001221766,0.0002193247,0.0001419747,0.0001887845,0.00006218623,0.0006199853,0.000004055084],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006564454,"about_ca_system_score_gemma":0.0001662961,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001107911,"about_ca_topic_score_gemma":0.002814002,"domain_scores_codex":[0.9970113,0.0003146278,0.001709375,0.0003280664,0.0002990186,0.0003375963],"domain_scores_gemma":[0.9977842,0.0006831117,0.000698949,0.0002347777,0.0004633538,0.0001355808],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04998203,0.05882104,0.7385829,0.000082145,0.009065971,0.01832656,0.00701688,0.0001183322,0.03813837,0.001814961,0.0003614531,0.07768936],"study_design_scores_gemma":[0.1108249,0.03475583,0.8483045,0.00106881,0.0001365011,0.002345477,0.001485763,0.0003479931,0.00009061871,0.0001518977,0.0002390902,0.0002485695],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960012,0.0003821325,0.0002288244,0.002618657,0.0002195902,0.0003186816,0.000001485761,0.00001102631,0.0002184209],"genre_scores_gemma":[0.9954685,0.003555697,0.000353461,0.0002861084,0.00018922,0.000005503458,0.000003514813,0.00002565853,0.0001123416],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1097216,"threshold_uncertainty_score":0.5537375,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04211529500310938,"score_gpt":0.3661663845066192,"score_spread":0.3240510895035098,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}